{"acquisitions":[],"changes":[],"country":"US","description":"Ceria Therapeutics develops RNA-interference therapies for acute inflammation in advanced wound, critical, and GI care, paired with in-house contract manufacturing for synthetic RNA and nanoparticles. It serves pharma developers who need both novel inflammation drugs and GMP-scale RNA/nanoparticle production. Capabilities include aerosolized formulation and analytics from research through GMP.","domain":"ceriatherapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":40.014986,"lng":-105.270545,"location":"BOULDER, Colorado","multiples":[],"name":"CERIA THERAPEUTICS INC","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2040784,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"ceriatherapeutics-com-2024-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"ceriatherapeutics-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"ceriatherapeutics.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://ceriatherapeutics.com"},{"fact":"description","publisher":"ceriatherapeutics.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://ceriatherapeutics.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress 6.9.4","Yoast SEO 27.6","jQuery Migrate 3.4.1","parallax.js","Cloudflare Bot Management","web-vitals","PHP","MySQL","jquery 3.7.1"],"totalRaisedUsd":2040784,"traction":[],"updatedAt":"2026-05-02","valuations":[]}